Talawar Therapeutics and Sanofi are joining forces via a definitive business combination agreement, planning a Nasdaq debut.
1 report, 1 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Talawar Therapeutics and Sanofi are joining forces via a definitive business combination agreement, planning a Nasdaq debut.